Full Press Release Details
Notice Under Section 708A(5)(e)
of the Corporations Act
This notice is given by Alterity
Therapeutics Limited ACN 080 699 065 (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), under section 708A(5)(e)
of the Corporations Act 2001 (Cth) (Corporations Act).
Details of securities issued
| Type | Shares |
| Class/Description | Fully paid ordinary shares |
| ASX Code | ATH |
| Date of Issue | 4 March 2024 |
| Number Issued | 855,263,158 |
The Company gives notice pursuant to
section 708A(5)(e) of the Corporations Act that:
CFO & Company Secretary
Alterity Therapeutics Limited
Level 3, 62 Lygon Street Carlton
Victoria 3053 Australia